Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Jaya Agra Wattie Tbk (JAWA) vs Organon Pharma Indonesia Tbk. (SCPI)

Jaya Agra Wattie TbkTrading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Jaya Agra Wattie Tbk dan Organon Pharma Indonesia Tbk.: Jaya Agra Wattie Tbk diperdagangkan di Rp148 (kapitalisasi pasar 2,69 T, volume 24 jam 16,53 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jaya Agra Wattie Tbk jauh lebih besar — sekitar 25,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

JAWASCPI
Kapitalisasi Pasar
2,69 T104,4 M
Volume
16,53 jt
Lot
165,29 rb
Perputaran
2,51 M
Harga Rata-rata
151,99
Nilai Transaksi
2,51 M
Harga Ekuilibrium Indikatif
148
Volume Ekuilibrium Indikatif
6,3 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

JAWA
Lihat detail
SCPI
Lihat detail

Tentang Jaya Agra Wattie Tbk

PT Jaya Agra Wattie was founded with the name Handel Maatschappij J.A. Wattie and Company Limited. PT Jaya Agra Wattie (Persero) is one of private agribusiness corporations engaging in plantation, processing and agricultural logistics and marketing activities. Having 90 years of experience in the agriculture sector, the company continually strengthens its business base through a diversification approach by cultivating various premium plantations of primary raw commodities such as rubber, crude palm oil (CPO), coffee and tea.

Selengkapnya di halaman JAWA

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI